Clinical Trial Update: Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC [Phase 2]

View source ↗

Summary

ClinicalTrials.gov report describes a Phase 2 neoadjuvant trial in resectable non-small cell lung cancer evaluating chemotherapy and immunotherapy with probioti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Probiotics

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage ⅢA | Phase 2 | Status: ACTIVE_NOT_RECRUITING